TY - JOUR
T1 - Recovery from anemia and leukocytopenia after abstinence in Japanese alcoholic men and their genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2
AU - Yokoyama, Akira
AU - Brooks, Philip J.
AU - Yokoyama, Tetsuji
AU - Mizukami, Takeshi
AU - Shiba, Shunsuke
AU - Nakamoto, Nobuhiro
AU - Maruyama, Katsuya
N1 - Publisher Copyright:
© The Author 2017. Published by Oxford University Press.
PY - 2017/4
Y1 - 2017/4
N2 - Background: The combination of the fast-metabolizing alcohol dehydrogenase-1B (ADH1B*2 allele) and inactive heterozygous aldehyde dehydrogenase-2 (ALDH2*1/*2) increases susceptibility to macrocytic anemia and leukocytopenia in alcoholics due to severe acetaldehydemia. More than half of Japanese drinkers with esophageal cancer have this genotype combination. Methods: To assess the recovery of hematologic abnormalities after drinking cessation, changes in blood erythrocyte indices and leukocyte count during 8-week hospital stay were evaluated in 925 Japanese alcoholic men. We used four categories in ascending order for high blood acetaldehyde exposure from drinking: A, ADH1B*1/*1 plus ALDH2*1/*1; B, ADH1B*2 plus ALDH2*1/*1; C, ADH1B*1/*1 plus ALDH2*1/*2; and D, ADH1B*2 plus ALDH2*1/*2. Results: Mean values of hemoglobin and hematocrit were the lowest, and those of mean corpuscular volume (MCV) were markedly the highest in the D group on admission, and returning toward normal after abstinence, but the inter-group differences remained significant throughout the 8 weeks. The mean leukocyte count was the lowest in the D group on admission, but increased during 4-week abstinence when the inter-group differences were no longer significant. Frequencies of MCV ≥110 fl (50.5%), hemoglobin levels < 11.5 g/dL (32.7%), hemoglobin levels < 10.0 g/dL (9.9%) and leukocytopenia < 4000/μL (22.8%) were the highest in the D group on the admission day and decreased at the 4-week abstinence (28.7%, 18.8%, 4.0% and 7.9%, respectively). The inter-group differences in frequencies of the severe anemia and leukocytopenia disappeared after 4-week abstinence.
AB - Background: The combination of the fast-metabolizing alcohol dehydrogenase-1B (ADH1B*2 allele) and inactive heterozygous aldehyde dehydrogenase-2 (ALDH2*1/*2) increases susceptibility to macrocytic anemia and leukocytopenia in alcoholics due to severe acetaldehydemia. More than half of Japanese drinkers with esophageal cancer have this genotype combination. Methods: To assess the recovery of hematologic abnormalities after drinking cessation, changes in blood erythrocyte indices and leukocyte count during 8-week hospital stay were evaluated in 925 Japanese alcoholic men. We used four categories in ascending order for high blood acetaldehyde exposure from drinking: A, ADH1B*1/*1 plus ALDH2*1/*1; B, ADH1B*2 plus ALDH2*1/*1; C, ADH1B*1/*1 plus ALDH2*1/*2; and D, ADH1B*2 plus ALDH2*1/*2. Results: Mean values of hemoglobin and hematocrit were the lowest, and those of mean corpuscular volume (MCV) were markedly the highest in the D group on admission, and returning toward normal after abstinence, but the inter-group differences remained significant throughout the 8 weeks. The mean leukocyte count was the lowest in the D group on admission, but increased during 4-week abstinence when the inter-group differences were no longer significant. Frequencies of MCV ≥110 fl (50.5%), hemoglobin levels < 11.5 g/dL (32.7%), hemoglobin levels < 10.0 g/dL (9.9%) and leukocytopenia < 4000/μL (22.8%) were the highest in the D group on the admission day and decreased at the 4-week abstinence (28.7%, 18.8%, 4.0% and 7.9%, respectively). The inter-group differences in frequencies of the severe anemia and leukocytopenia disappeared after 4-week abstinence.
KW - Alcohol dehydrogenase-1B
KW - Aldehyde dehydrogenase-2
KW - Esophageal cancer
KW - Leukocyte
KW - Macrocytic anemia
UR - http://www.scopus.com/inward/record.url?scp=85021762280&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85021762280&partnerID=8YFLogxK
U2 - 10.1093/jjco/hyw208
DO - 10.1093/jjco/hyw208
M3 - Article
C2 - 28158658
AN - SCOPUS:85021762280
SN - 0368-2811
VL - 47
SP - 306
EP - 312
JO - Japanese journal of clinical oncology
JF - Japanese journal of clinical oncology
IS - 4
ER -